MD Anderson study first to compare treatments, survival benefits for early-stage lung cancer

Removal of the entire lobe of lung may offer patients with early-stage lung cancer better overall survival when compared with a partial resection, and stereotactic ablative radiotherapy (SABR) may offer the same survival benefit as a lobectomy for some patients, according to a study from The University of Texas MD Anderson Cancer Center. The research is the largest population-based study to review modern treatment modalities for early-stage lung cancer. Read more here.